🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 13

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 13 of 20
RickReta_CO
Member
312
1,234
Jan 2025
Colorado
Feb 19, 2025 at 10:00 PM#61
Dr.PathRoch said:
One practical note: write down what you did and when, before you need it.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Feb 20, 2025 at 3:00 AM
2 0matt_MKE, Dr.ReproEndo
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Feb 28, 2025 at 2:33 AM#62
Dr.PathRoch said:
One practical note: write down what you did and when, before you need it.

That reframing is the part I needed.

3 1TrialNerd_Beth, HPLC_Greg, LibrarianMeg
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Mar 8, 2025 at 7:01 AM#63

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

4 2HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Mar 16, 2025 at 11:25 AM#64

Reporting back.

Closing this out. What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and worth saying anyway.

5 3Dr.PulmRoch, maya_sedona, stefan_berlin and 2 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Mar 24, 2025 at 3:44 PM#65
Dr.MetabolicMD said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

There is a second half to this that has not been said yet. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Mar 24, 2025 at 5:44 PM
6 4SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 3 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register